M. A. N. Şendur Et Al. , "Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer," Medical Oncology , vol.31, no.4, 2014
Şendur, M. A. N. Et Al. 2014. Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer. Medical Oncology , vol.31, no.4 .
Şendur, M. A. N., Uncu, D., & ZENGİN, N., (2014). Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer. Medical Oncology , vol.31, no.4.
Şendur, Mehmet, Dogan Uncu, And NURULLAH ZENGİN. "Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer," Medical Oncology , vol.31, no.4, 2014
Şendur, Mehmet A. Et Al. "Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer." Medical Oncology , vol.31, no.4, 2014
Şendur, M. A. N. Uncu, D. And ZENGİN, N. (2014) . "Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer." Medical Oncology , vol.31, no.4.
@article{article, author={Mehmet Ali Nahit Şendur Et Al. }, title={Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer}, journal={Medical Oncology}, year=2014}